ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.18
+0.46 (2.12%)
At close: May 13, 2026, 4:00 PM EDT
22.21
+0.03 (0.14%)
After-hours: May 13, 2026, 5:37 PM EDT

ACADIA Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,7984,5493,0595,1552,5803,758
Market Cap Growth
57.80%48.70%-40.66%99.81%-31.34%-55.96%
Enterprise Value
2,9973,7702,3454,7642,2163,293
Last Close Price
22.1826.7118.3531.3115.9223.34
PE Ratio
10.1011.6113.49-84.62-11.88-22.23
Forward PE
40.9140.3835.9027.40--
PS Ratio
3.474.253.197.104.997.76
PB Ratio
3.043.714.1711.946.446.95
P/TBV Ratio
3.043.704.1711.886.436.93
P/FCF Ratio
33.4443.2619.46309.58-22.63-29.64
P/OCF Ratio
30.7541.4219.40308.66-22.63-29.91
EV/Sales Ratio
2.743.522.456.564.286.80
EV/EBITDA Ratio
32.3332.349.51-70.24-9.91-19.71
EV/EBIT Ratio
37.0535.9710.16-64.92-9.91-19.32
EV/FCF Ratio
26.3935.8514.92286.10-19.43-25.98
Debt / Equity Ratio
0.030.030.060.110.130.10
Debt / EBITDA Ratio
0.420.350.17-0.70-0.24-0.34
Debt / FCF Ratio
0.340.390.272.87-0.46-0.44
Net Debt / Equity Ratio
-0.65-0.63-0.97-0.91-0.91-0.86
Net Debt / EBITDA Ratio
-8.76-6.68-2.895.771.632.78
Net Debt / FCF Ratio
-7.15-7.41-4.54-23.483.193.66
Asset Turnover
0.690.780.991.090.800.65
Inventory Turnover
2.823.142.831.961.402.18
Quick Ratio
3.273.492.182.133.826.10
Current Ratio
3.593.832.382.424.046.43
Return on Equity (ROE)
30.35%39.89%38.89%-14.73%-45.89%-28.75%
Return on Assets (ROA)
16.66%21.44%20.91%-13.18%-35.13%-23.04%
Return on Invested Capital (ROIC)
57.67%117.01%436.78%-174.15%-351.57%-266.79%
Return on Capital Employed (ROCE)
6.26%10.08%35.85%-15.34%-41.94%-26.62%
Earnings Yield
9.89%8.61%7.41%-1.18%-8.42%-4.50%
FCF Yield
2.99%2.31%5.14%0.32%-4.42%-3.37%
Buyback Yield / Dilution
-2.73%-2.14%-1.55%-1.32%-0.74%-2.01%
Total Shareholder Return
-2.73%-2.14%-1.55%-1.32%-0.74%-2.01%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q